$2.22
0.04[1.83%]
At close: Apr 23
$2.22
0[0.00%]
After Hours: 4:01PM EDT
Coherus BioSciences
(NASDAQ:CHRS)Coherus BioSciences Stock (NASDAQ:CHRS), Earnings Estimates, EPS, and Revenue
Coherus BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$92M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$257.2M
Analyze the earnings history of Coherus BioSciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | PM | CHRS | Q1 | -$0.75 | -$0.23 | — | — | $32.44M | $91.98M | — | — | Get Alert |
| 03/13/2024 | PM | CHRS | Q4 | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | Get Alert |
| 11/06/2023 | PM | CHRS | Q3 | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | Get Alert |
| 08/02/2023 | PM | CHRS | Q2 | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | Get Alert |
| 05/08/2023 | PM | CHRS | Q1 | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | Get Alert |
| 03/06/2023 | PM | CHRS | Q4 | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | Get Alert |
| 11/08/2022 | PM | CHRS | Q3 | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | Get Alert |
| 08/04/2022 | PM | CHRS | Q2 | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | Get Alert |
| 05/05/2022 | PM | CHRS | Q1 | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | Get Alert |
| 02/17/2022 | PM | CHRS | Q4 | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | Get Alert |
| 11/08/2021 | PM | CHRS | Q3 | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | Get Alert |
| 08/05/2021 | PM | CHRS | Q2 | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | Get Alert |
| 05/06/2021 | PM | CHRS | Q1 | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | Get Alert |
| 02/24/2021 | PM | CHRS | Q4 | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | Get Alert |
| 11/05/2020 | PM | CHRS | Q3 | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | Get Alert |
| 08/06/2020 | PM | CHRS | Q2 | $0.32 | $0.33 | $0.81 | 145.45% | $83.43M | $104.95M | $135.67M | 29.27% | Get Alert |
| 05/07/2020 | PM | CHRS | Q1 | -$0.29 | $0.56 | $0.48 | -14.29% | $37.10M | $119.52M | $116.18M | -2.79% | Get Alert |
| 02/27/2020 | PM | CHRS | Q4 | -$0.92 | $0.72 | $0.53 | -26.39% | $0.00 | $123.01M | $123.86M | 0.69% | Get Alert |
| 11/06/2019 | PM | CHRS | Q3 | -$0.87 | $0.51 | $0.63 | 23.53% | $0.00 | $101.37M | $111.68M | 10.17% | Get Alert |
FAQ
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences (CHRS) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 13, 2024 for Q4.
What were the latest earnings per share (EPS) for Coherus BioSciences (NASDAQ:CHRS)?
The Actual EPS was $-0.62, which missed the estimate of $-0.12.
What were Coherus BioSciences’s (NASDAQ:CHRS) revenues?
The Actual Revenue was $91.5M, which missed the estimate of $96.4M.
Browse earnings estimates, EPS, and revenue on all stocks.